home / stock / cprx / cprx quote
Last: | $17.2399 |
---|---|
Change Percent: | 1.41% |
Open: | $16.93 |
Close: | $17 |
High: | $17.34 |
Low: | $16.8901 |
Volume: | 255,336 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$17.2399 | $16.93 | $17 | $17.34 | $16.8901 | 255,336 | 07-23-2024 |
$17 | $16.96 | $17 | $17.065 | $16.74 | 671,214 | 07-22-2024 |
$16.94 | $16.8 | $16.94 | $17.02 | $16.6901 | 527,322 | 07-19-2024 |
$16.72 | $16.95 | $16.72 | $17 | $16.62 | 653,362 | 07-18-2024 |
$16.9 | $16.81 | $16.9 | $17.235 | $16.75 | 853,464 | 07-17-2024 |
$16.99 | $16.97 | $16.99 | $17.23 | $16.6783 | 964,273 | 07-16-2024 |
$16.75 | $16.7 | $16.75 | $17.01 | $16.5805 | 831,467 | 07-15-2024 |
$16.58 | $16.5 | $16.58 | $16.91 | $16.38 | 869,095 | 07-12-2024 |
$16.31 | $15.77 | $16.31 | $16.43 | $15.64 | 965,180 | 07-11-2024 |
$15.46 | $15.71 | $15.46 | $15.74 | $15.26 | 502,428 | 07-10-2024 |
$15.61 | $15.37 | $15.61 | $15.62 | $15.185 | 646,842 | 07-09-2024 |
$15.45 | $15.34 | $15.45 | $15.66 | $15.32 | 598,403 | 07-08-2024 |
$15.19 | $15.36 | $15.19 | $15.38 | $14.97 | 603,310 | 07-05-2024 |
$15.31 | $15.88 | $15.31 | $15.92 | $15.3 | 389,670 | 07-04-2024 |
$15.31 | $15.88 | $15.31 | $15.92 | $15.3 | 389,670 | 07-03-2024 |
$15.8 | $15.73 | $15.8 | $15.83 | $15.61 | 773,594 | 07-02-2024 |
$15.77 | $15.52 | $15.77 | $15.97 | $15.49 | 837,171 | 07-01-2024 |
$15.49 | $15.18 | $15.49 | $15.52 | $15.04 | 1,920,395 | 06-28-2024 |
$15.04 | $15.12 | $15.04 | $15.18 | $14.96 | 601,718 | 06-27-2024 |
$15.08 | $15.05 | $15.08 | $15.12 | $14.75 | 957,111 | 06-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-...
2024-06-20 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-03 11:30:04 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform. CPRX was trading at $16.38 at issue of the analyst recommendation. The overall analyst consensus :...